Non-alcoholic fatty liver disease (NAFLD), insulin resistance and lipid profile in antiepileptic drug treatment.
Luef G, Rauchenzauner M, Waldmann M, Sturm W, Sandhofer A, Seppi K, Trinka E, Unterberger I, Ebenbichler CF, Joannidis M, Walser G, Bauer G, Hoppichler F, Lechleitner M.
Luef G, et al. Among authors: unterberger i.
Epilepsy Res. 2009 Sep;86(1):42-7. doi: 10.1016/j.eplepsyres.2009.04.004. Epub 2009 May 22.
Epilepsy Res. 2009.
PMID: 19464851